Novadip Biosciences raises €40m for orthopaedic products development
Novadip Biosciences, a Belgium-based biopharmaceutical company, has raised an additional €40 million in a Series B equity round and non-dilutive funding. The proceeds will be used for accelerating the clinical development of two of its investigational adipose stem cell (ASC)-derived tissue regeneration products — NVD-X3 and NVD-003. With €24 million in new equity and €16 […]